Cencora Inc.
Cencora Reports Q1 2026 Results and Completes Acquisition of OneOncology
Summary
Cencora, Inc. reported its fiscal 2026 first quarter results on February 4, 2026, showing a 5.5% year-over-year revenue increase to $85.9 billion. The company's GAAP diluted EPS was $2.87, and adjusted diluted EPS was $4.08. Cencora updated its fiscal 2026 guidance, raising its adjusted operating income outlook to 11.5% to 13.5% growth, reflecting the OneOncology acquisition completed on February 2, 2026, for approximately $4.6 billion. The acquisition is expected to consolidate OneOncology's operating results within the U.S. Healthcare Solutions segment. Cencora also declared a quarterly cash dividend of $0.60 per common share, payable on March 2, 2026. For detailed financial results and guidance, investors are directed to the news release attached as Exhibit 99.1 and the company's website.
Profitelligence Alerts
Get alerts for COR
Be first to know when Cencora Inc. files with the SEC.
Filing Categories
Advertisement
About Cencora Inc.
Cencora Inc., formerly known as AmerisourceBergen Corporation, represents a pivotal entity in the global healthcare distribution and services sector. As a leading pharmaceutical sourcing and distribution services company, Cencora Inc. plays a critical role in ensuring the efficient supply of pharmaceutical products to a range of healthcare providers, including hospitals, pharmacies, and clinics. Its business model is centered on the seamless integration of logistics, consulting services, and the provision of innovative solutions aimed at improving pharmaceutical supply chain operations. Cencora Inc. impacts various segments of the healthcare industry by enhancing the availability and accessibility of healthcare products. Known for its global reach and extensive network of distribution centers, the company supports the delivery of critical medications and healthcare products across numerous geographies. Cencora Inc.'s significance in the market is underscored by its ability to partner with pharmaceutical manufacturers and healthcare providers to streamline processes, reduce costs, and improve patient outcomes. Headquartered in Conshohocken, Pennsylvania, Cencora Inc. remains a cornerstone of the healthcare distribution market, focusing on sustainability, innovation, and strategic collaborations.
Official SEC Documents
Advertisement